Wraith EJ - Search Results

1

Laronidase treatment of mucopolysaccharidosis I.

Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA. Wraith EJ, et al. BioDrugs. 2005;19(1):1-7. doi: 10.2165/00063030-200519010-00001. BioDrugs. 2005. PMID: 15691212 Review.

2

Update on mucopolysaccharidosis type II.

Beck M, Wraith E. Beck M, et al. Acta Paediatr. 2007 Apr;96(455):55. doi: 10.1111/j.1651-2227.2007.00210.x. Acta Paediatr. 2007. PMID: 17391444 No abstract available.

3

Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease.

Church H, Tylee K, Cooper A, Thornley M, Mercer J, Wraith E, Carr T, O'Meara A, Wynn RF. Church H, et al. Bone Marrow Transplant. 2007 Feb;39(4):207-10. doi: 10.1038/sj.bmt.1705569. Epub 2007 Jan 15. Bone Marrow Transplant. 2007. PMID: 17220904

4

Craniovertebral abnormalities in Type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).

Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA. Thorne JA, et al. Neurosurgery. 2001 Apr;48(4):849-52; discussion 852-3. doi: 10.1097/00006123-200104000-00031. Neurosurgery. 2001. PMID: 11322445

5

Does the timing of treatment affect the ocular phenotype in patients with Mucopolysaccharidosis I homozygous for the L490P mutation?

Chan WH, Biswas S, Lloyd IC, Wraith E, Jones S, Mercer J, Ashworth JL. Chan WH, et al. Eye (Lond). 2013 Sep;27(9):1112-4. doi: 10.1038/eye.2013.109. Epub 2013 Jun 7. Eye (Lond). 2013. PMID: 23743524 Free PMC article. No abstract available.

6

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.

Moore D, Connock MJ, Wraith E, Lavery C. Moore D, et al. Orphanet J Rare Dis. 2008 Sep 16;3:24. doi: 10.1186/1750-1172-3-24. Orphanet J Rare Dis. 2008. PMID: 18796143 Free PMC article.

7

Mucopolysaccharidoses and the eye.

Ashworth JL, Biswas S, Wraith E, Lloyd IC. Ashworth JL, et al. Surv Ophthalmol. 2006 Jan-Feb;51(1):1-17. doi: 10.1016/j.survophthal.2005.11.007. Surv Ophthalmol. 2006. PMID: 16414358 Review.

8

The ocular features of the mucopolysaccharidoses.

Ashworth JL, Biswas S, Wraith E, Lloyd IC. Ashworth JL, et al. Eye (Lond). 2006 May;20(5):553-63. doi: 10.1038/sj.eye.6701921. Eye (Lond). 2006. PMID: 15905869

9

Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.

Tomatsu S, Okamura K, Taketani T, Orii KO, Nishioka T, Gutierrez MA, Velez-Castrillon S, Fachel AA, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Noguchi A. Tomatsu S, et al. Pediatr Res. 2004 Apr;55(4):592-7. doi: 10.1203/01.PDR.0000113767.60140.E9. Epub 2004 Jan 7. Pediatr Res. 2004. PMID: 14711889

10

Otorhinolaryngological manifestations of the mucopolysaccharidoses.

Simmons MA, Bruce IA, Penney S, Wraith E, Rothera MP. Simmons MA, et al. Int J Pediatr Otorhinolaryngol. 2005 May;69(5):589-95. doi: 10.1016/j.ijporl.2005.01.017. Int J Pediatr Otorhinolaryngol. 2005. PMID: 15850680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page